The Ministry of Health of the Republic of Indonesia and the CRUK Scotland Institute have entered into a landmark partnership to advance cancer research, build capacity in cancer care, and support evidence-based health policies through the signing of a Memorandum of Understanding (MoU). 

Dr Susanti Susanti, an Indonesian researcher based at the CRUK Scotland Institute and herself a bowel cancer survivor, has been instrumental in bringing colleagues from both Scotland and Indonesia together to drive forward this collaboration..  

In Indonesia, cancer is one of the top non-communicable diseases contributing to morbidity and mortality, with breast, cervical, and lung cancers among the most prevalent.  

The Indonesian Ministry of Health has launched a range of efforts, including strengthening early detection programmes, expanding access to treatment, and developing national cancer control plans. 

The partnership is part of Indonesia’s strategy of establishing international research collaborations with leading institutions. 

The MoU was signed in Glasgow by Professor Owen Sansom, Director of the CRUK Scotland Institute, and subsequently signed in Jakarta by Dr. Azhar Jaya, Director General of Health Services, Ministry of Health of the Republic of Indonesia.  

The Jakarta signing took place during the UK–Indonesia Medical Genomics Summit 2025 held on 2 May 2025 at RSK Dharmais. 

Dr Susanti Susanti, CEO and Founder of PathGen Diagnostik Teknologi in Indonesia and Postdoctoral Researcher at the CRUK Scotland Institute in Glasgow, said: “As a cancer survivor, I know the challenge of combating cancer is immense but am hopefully that through this collaboration we can make a difference for patients in both Indonesia and the UK.”

Diana Spencer, Senior Digital Content Editor, DDW